Peter A Kiener Insider Trading
Get free email notifications about insider trading for Peter A Kiener.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter A Kiener. Peter A Kiener is a Chief Science Officer in Sucampo Pharmaceuticals, Inc. ($SCMP) and a Chief Scientific Officer in Sucampo Pharmaceuticals, Inc. ($SCMP) and a in PIERIS PHARMACEUTICALS, INC. ($PIRS) and a Director in Cue Biopharma, Inc. ($CUE).
Address: ONE MEDIMMUNE WAY GAITHERSBURG 20878 MD
Companies in which Peter A Kiener is an Insider
Cue Biopharma, Inc.
Trading Symbol: CUEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter A Kiener: Director
Holdings: 0 shares
Latest Transaction: Jan 06 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PIERIS PHARMACEUTICALS, INC.
Trading Symbol: PIRSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter A Kiener:
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 25 2020
$PIRS Market Capitalization: $91.71M
$PIRS Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sucampo Pharmaceuticals, Inc.
Trading Symbol: SCMPIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter A Kiener: Chief Science Officer, Chief Scientific Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 13 2018
$SCMP Market Capitalization: $496.69M
$SCMP Previous Close: $11.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Peter A Kiener
Sentiment: All, CUE, PIRS, SCMP
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 06 2021 | CUE | Cue Biopharma, Inc ... | Kiener Peter A | Director | Option Exercise | A | 12.36 | 10,000 | 123,600 | 10,000 | |
Jun 25 2020 | PIRS | PIERIS PHARMACEUTI ... | Kiener Peter A | Option Exercise | A | 3.27 | 40,000 | 130,800 | 40,000 | ||
Jun 25 2020 | PIRS | PIERIS PHARMACEUTI ... | Kiener Peter A | Option Exercise | A | 3.27 | 40,000 | 130,800 | 40,000 | ||
Jan 28 2020 | PIRS | PIERIS PHARMACEUTI ... | Kiener Peter A | Option Exercise | A | 3.23 | 20,000 | 64,600 | 20,000 | ||
Jan 29 2019 | PIRS | PIERIS PHARMACEUTI ... | Kiener Peter A | Option Exercise | A | 2.74 | 20,000 | 54,800 | 20,000 | ||
Oct 25 2018 | PIRS | PIERIS PHARMACEUTI ... | Kiener Peter A | Option Exercise | A | 4.46 | 30,000 | 133,800 | 30,000 | ||
Jun 14 2018 | CUE | Cue Biopharma, Inc ... | Kiener Peter A | Director | Option Exercise | M | 14.24 | 9,600 | 136,704 | 9,600 |